Tagbo, Bb Girl .
HRN: 26-14-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2024
AMPICILLIN 250MG (VIAL)
12/10/2024
12/17/2024
IV
100 Mg
Q12h
Sepsis Neonatorum
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes